Watch RVRC. Know when insiders buy.
One email the day a filing lands. Free.
RVRC
Revium Rx.
1.43
+0.00 +0.00%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $86.8MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$13.4MNET CASH —52W 0.52 – 1.67SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$732K | −$748K | — | 0.01 | −$626K | — | — | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$739K | −$725K | — | 0.01 | −$541K | — | — | Aug 13 |
| Q2 2025 · Jun 30 | — | — | — | −$938K | −$1M | — | 0.02 | −$759K | — | — | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$737K | −$634K | — | 0.01 | −$357K | — | — | Aug 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | −$13.4M | — | -0.22 | — | — | — | — | — |
Every number comes from Revium Rx.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.